Navigation Links
Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S.
Date:8/26/2009

CHADDS FORD, Pa., Aug. 26 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.

FORTESTA, a patented 2 percent testosterone transdermal gel for testosterone replacement therapy in male hypogonadism, utilizes a metered dose delivery system designed to permit accurate dose adjustment to individual patient requirements. This product is in registration in the U.S., where the Food and Drug Administration (FDA) is currently reviewing ProStrakan's New Drug Application submission.

Under the terms of the agreement, Endo Pharmaceuticals has agreed to make an upfront payment to ProStrakan of $10 million, with the potential for up to $40 million more in milestone payments by the end of 2010 for regulatory approval and the achievement of certain commercial milestones. Endo Pharmaceuticals has also agreed to pay ProStrakan an additional $160 million upon the achievement of certain sales targets. ProStrakan will exclusively supply FORTESTA to Endo Pharmaceuticals in the U.S. for an undisclosed supply price.

"We are committed to advancing men's health with effective new medicines. Being in a position to potentially offer this treatment, alongside our new long-acting injectable testosterone product, will help fill an important gap in testosterone replacement," said David Holveck, president and chief executive officer of Endo Pharmaceuticals. "This treatment option is synergistic with our recent therapeutic expansion and strengthens our portfolio in urology and endocrinology."

About FORTESTA

FORTESTA (branded variously as Tostran, Tostrex
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
2. Robin Leedy & Associates Wins Social Media Program For Union Springs Pharmaceuticals
3. Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
4. Raptor Pharmaceuticals Raises $5 Million
5. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
6. The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.
7. NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
8. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
9. Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
10. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
11. Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Palm City, Florida (PRWEB) January 22, 2015 ... use cold therapy machine with patented IsoTube design to treat ... has introduced the most progressive and easy to use ... help treat post-operative and sports related orthopedic and muscle injuries. ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... have been able to bring an improvement in the ... pulmonary disease (COPD) by teaching them to play the ... of a pulmonary rehabilitation class at the university. The ... chronic obstructive pulmonary disease can focus on their breathing ...
... from osteoporosis from loss of bone mass, there may be ... that it can help improve bone mass in women who ... the principal recommendations for preventing and treating the loss of ... always possible, particularly for the frail., ,An experimental device ...
... of Archives of Internal Medicine said that doctors might ... bio-terrorism that may be caused by smallpox, anthrax, botulism ... tested were unable to correctly diagnose diseases caused by ... test scores improved dramatically for the same physicians after ...
... you are a smoker, says a new study. ... Forest University School of Medicine// examined the relationship between ... study, reports science portal EurekAlert. ,They compared the ... among those who had never smoked. ,Twenty-five percent ...
... the excess weight that one has to carry like excess ... best way is that adopted earlier that is the basic ... Obesity is a big problem these days. , ,Calorie ... of approach towards weight control. ,With so many dietary ...
... walnut sized gland present below the urinary bladder in males. ... that add volume to the semen//. Prostate cancer is the ... of cancer death in American men. The incidence of the ... to cancer prevention, an assessment of the risk factors is ...
Cached Medicine News:
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader ... and partnership with RCA Medical, a subsidiary of Ascendis ... . Each year, hundreds of millions of ... infections as organisms are transmitted from patient to patient ...
(Date:1/23/2015)... Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number of ... compound, LB‑100, is being conducted, has been expanded from 1 ... M.D., the founder and President of Lixte, said that, "the ... site. Accrual of patients, however, was slower than projected. The ...
(Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... , INDIANAPOLIS, Oct. 21 , Higher volume drives revenue growth ... increase to $.86 (reported) or $1.20 (pro forma non-GAAP) Full-year 2009 EPS ... , Eli Lilly and Company (NYSE: LLY ) today announced financial ... per share data Third Quarter, ...
... Massachusetts, October 21 Shire plc,(LSE: SHP, NASDAQ: ... file a Biologics License Application (BLA) with the U.S.,Food ... replacement therapy for Fabry disease, by the end of ... for REPLAGAL, filed at the,request of FDA, has been ...
Cached Medicine Technology:Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 2Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 3Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 4Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 5Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 6Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 7Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 8Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 9Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 10Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 11Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 12Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 13Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 14Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 15Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 16Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 17Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 18Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 19Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 20Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 21Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
... license agreement between Brook Brothers and ... Characterized by lightweight materials and a ... reflect the unique features of the ... product with classic style and affordable ...
... The new Eyewear collection is a ... and sophisticated in the House of Salvatore ... four mens, as well as up-dates of ... Florentine brand reassert themselves in a brilliant ...
... Vision eyewear includes three collections - Nike ... Ophthalmics, offering active lifestyle consumers the latest ... performance. The sun collections feature Nikes Max ... in a larger vision sweet spot for ...
... technology has redefined rimless collections forever.,The Airlock ... the end of each frame mounting. This ... bushing that mounts within the lens. When ... fit is created that far exceeds that ...
Medicine Products: